Welcome to the Jungle: Probiotics in the Preterm Infant
Course Description:In this course, you’ll discuss the alteration of the gut microbiome in preterm infants; review recent evidence-based literature on probiotic use in the NICU; and discuss the risks vs. benefits with the use of probiotics in preterm infants.
- Discuss the alteration of the gut microbiome in preterm infants leading to dysbiosis and associated morbidities.
- Review recent evidence-based literature on probiotic use in the NICU.
- Discuss the risks vs. benefits with the use of probiotics in preterm infants.
- CDR Level: 1
- Suggested Learning Codes: 4040, 5000, 5060, 9020
- Performance Indicators: 4.1.2, 8.1.2, 8.1.4, 8.3.6
- Run Time: 42
Course Instructor Bio(s)
Steven J. McElroy, MD
Dr. Steven McElroy is an Associate Professor of Pediatrics – Neonatology, and an Associate Professor of Microbiology and Immunology at the University of Iowa. His current research and work focus is on the mechanisms of gastrointestinal epithelial cell injury and repair during development, especially as it relates to neonatal necrotizing enterocolitis (NEC). The long-term goal is to better understand how different gastrointestinal developmental stages differ in their response to inflammation, and specifically the mechanism by which immaturity of the small intestine predisposes development of NEC. His laboratory developed a novel model of NEC [in mice] that uses Paneth cell ablation to induce intestinal pathology that is consistent with human NEC.
attended a live program?
FREQUENTLY ASKED QUESTIONS
continuing medical education courses
Earn CME credits at no cost to you.